Orchard Therapeutics PLC (NASDAQ:ORTX)

BATS BZX Real-Time Price
As of 11:30am ET
 -0.0057 / -0.95%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +656.18% increase from the last price of 0.60.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Orchard Therapeutics PLC. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 42.14%
Growthannually 3.91%


Growthquarterly 0.27%
Growthannually 1,047.12%
Key to the earnings and sales forecast charts.